Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension
- PMID: 24679497
- DOI: 10.1016/j.cld.2013.12.004
Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension
Abstract
A transjugular intrahepatic portosystemic shunt (TIPS) is an expandable metal stent inserted via the jugular vein that creates a shunt from the portal vein to the systemic circulation via an artificial communication through the liver. It is used to treat complications of portal hypertension. In addition to rescue treatment in variceal bleeding, TIPS can play an important role in prevention of rebleeding. TIPS can improve symptoms if medical treatment of ascites or hepatic hydrothrorax has failed, but may not improve survival. Selected cases of Budd-Chiari syndrome improve with TIPS. This article discusses the indications, evidence, and complications of TIPS.
Keywords: Ascites; Portal hypertension; Transjugular intrahepatic portosystemic shunt; Varices.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
The transjugular intrahepatic portosystemic shunt: an update.AJR Am J Roentgenol. 2012 Oct;199(4):746-55. doi: 10.2214/AJR.12.9101. AJR Am J Roentgenol. 2012. PMID: 22997364 Review.
-
The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S344-51. doi: 10.1097/MCG.0b013e318157e500. J Clin Gastroenterol. 2007. PMID: 17975487 Review.
-
Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.Rofo. 2018 Aug;190(8):701-711. doi: 10.1055/a-0628-7347. Epub 2018 Jul 25. Rofo. 2018. PMID: 30045395 Review. English, German.
-
[Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].Zentralbl Chir. 2005 Jun;130(3):246-9. doi: 10.1055/s-2005-836547. Zentralbl Chir. 2005. PMID: 15965878 Review. German.
-
Transjugular Intrahepatic Portosystemic Shunt for Preventing Rebleeding of Esophageal Varices in Patients with Portal Cavernous Transformation.Dig Dis Sci. 2025 May;70(5):1897-1905. doi: 10.1007/s10620-025-08955-7. Epub 2025 Mar 3. Dig Dis Sci. 2025. PMID: 40032713 Free PMC article.
Cited by
-
Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites.World J Gastrointest Surg. 2024 Feb 27;16(2):481-490. doi: 10.4240/wjgs.v16.i2.481. World J Gastrointest Surg. 2024. PMID: 38463353 Free PMC article.
-
Emergency Transjugular Intrahepatic Portosystemic Shunt: an Effective and Safe Treatment for Uncontrolled Variceal Bleeding.J Gastrointest Surg. 2019 Nov;23(11):2193-2200. doi: 10.1007/s11605-019-04146-8. Epub 2019 Feb 21. J Gastrointest Surg. 2019. PMID: 30790218
-
Combination therapy versus pharmacotherapy, endoscopic variceal ligation, or the transjugular intrahepatic portosystemic shunt alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized controlled trials.Oncotarget. 2017 May 24;8(34):57399-57408. doi: 10.18632/oncotarget.18143. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915680 Free PMC article.
-
Therapeutic effects and complications of simplified pericardial devascularization for patients with portal hypertension.Int J Clin Exp Med. 2015 Aug 15;8(8):14036-41. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26550364 Free PMC article.
-
Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation.PLoS One. 2017 May 11;12(5):e0177401. doi: 10.1371/journal.pone.0177401. eCollection 2017. PLoS One. 2017. PMID: 28494001 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources